The Health Research Alliance (HRA) is a collaborative member organization of non-profit research funders that is committed to maximizing the impact of biomedical research to improve human health. They represent over 85 non-profit funders that have invested nearly $14 billion in biomedical research and training.
HRA solicited feedback from its members on how they are preparing for or responding to COVID-19, and combined this data with information compiled by a team at the Simons Foundation. They’ve consolidated the information into one spreadsheet, which contains data from 80 non-profit sponsors.
Also see additional guidance received directly by UCSF from the following sponsors:
California Wellness
Topic | Guidance |
Late Submission Policy | No guidance at this time |
Pre-Award Costs | No guidance at this time |
No-Cost Extensions | Principal Investigators should work with OSR to email [email protected] and they will connect you with the staff managing your grant in order to extend the grant period. |
Carry Forward of an Unobligated Balance | No guidance at this time. |
Expenditure of Awards Funds for Salaries, Stipends and Other Project Activities | If the work you were hoping to accomplish has been disrupted or impacted due to current conditions, then you may reallocate Cal Wellness grant dollars to help you address the crisis. |
Delays in Research Progress Including Financial and Other Reporting | Any reporting requirements with a due date of 12/31/2020 or before will automatically receive a six-month extension. There is no need to take additional action on your part. |
Travel Costs | No guidance at this time. |
California Institute for Regenerative Medicine (CIRM)
Topic | Guidance |
Late Submission Policy | No guidance at this time. |
Pre-Award Costs | No guidance at this time. |
No-Cost Extensions | Inception, Quest and other non-milestone research awards will be allowed no-cost extensions beyond the allowable limit in the Notice of Award. For these award types that require a no-cost extension, awardees should work with OSR to submit a Prior Approval request 30 days prior to the original project end date via the CIRM Grants Management System. |
Carry Forward of an Unobligated Balance | No guidance at this time. |
Expenditure of Awards Funds for Salaries, Stipends and Other Project Activities | As project activities begin to reduce or come to a halt, CIRM expects that awardees will appropriately reduce project expenditures and if required use contingency funding. During this time, a reduction in personnel effort is expected but we hope that you are able to retain the critical expertise on your project teams so that projects can begin work when able. CIRM will waive Principal Investigator and Project Manager effort requirements beginning March 2020 until work can continue. A Prior Approval Request is not required for this change. |
Delays in Research Progress Including Financial and Other Reporting | For Clinical, Translational and Infrastructure awardees,CIRM will not terminate awards for operational milestone delays due to the impact of COVID-19. No formal request to CIRM is required. For those of you who are running clinical trials, the FDA has issued a new guidance document entitled, FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic Guidance for Industry, Investigators, and Institutional Review Boards, March 2020. |
Travel Costs | No guidance at this time |
Cancer Research UK (CRUK)
CRUK website: Coronavirus (COVID-19): Information for grant applicants and grantholders
Topics Covered
- Applying for Cancer Research UK Funding - delay of Spring funding round
- For CRUK grantholders - addressed cuts to funding, spending flexibilities, requesting NCE, and other flexibilities
Mount Zion Health Fund
Mount Zion Health Fund (MZHF) exercises flexibility in response to the effects of COVID-19. Principal Investigator should work with OSR to contact MZHF.
Packard Foundation, The David & Lucile
These flexibilities will be adjusted as circumstances affected by COVID-19 evolve. Please continue to provide feedback to program staff at [email protected].
Topic | Guidance |
Late Submission Policy | No guidance at this time. |
Pre-Award Costs | No guidance at this time. |
No-Cost Extensions |
|
Carry Forward of an Unobligated Balance | No guidance at this time. |
Expenditure of Awards Funds for Salaries, Stipends and Other Project Activities |
|
Delays in Research Progress Including Financial and Other Reporting | All grantees will automatically receive a 4-month extension for any grant report due between February 28 and June 30. Project timelines or additional reporting deadline will be adjusted as needed. |
Travel Costs | Funds expended for planned events that are now cancelled and not refundable can be charged to related grants without modification to the grant agreement. |
Patient-Centered Outcomes Research Institute (PCORI)
Topic | Guidance |
Late Submission Policy |
|
Pre-Award Costs | No guidance at this time. |
No-Cost Extensions | Given the fluid situation, PCORI understands that awards might be delayed in completion. It is in the best interest of PCORI and the entire medical community to confront the immediate challenges and impact of the current crisis. In the future, it is anticipated that delays/modifications will be addressed on a case-by-case basis. More information on project/budget modifications will be posted at a later date. To the extent possible, please notify your PCORI staff person as soon as possible of any delays or modifications, along with supporting documentation. |
Carry Forward of an Unobligated Balance | No guidance at this time. |
Expenditure of Awards Funds for Salaries, Stipends and Other Project Activities | Maintaining integrity of project teams during this time is a high priority for PCORI. PCORI staff are working to address this concern regarding pay for salaries of researchers unable to work as a result of or related to the effects of COVID-19. Will update when future guidance is received. Please contact your PCORI staff person for additional information and continue to check this website for changes or updates to PCORI guidance. |
Delays in Research Progress Including Financial and Other Reporting |
|
Travel Costs | PCORI will reimburse institutions for non-refundable costs associated with grant related travel that has been cancelled on a case-by-case basis. Please contact your PCORI staff person. |
UCOP Research Grants Program Office (RPGO)
Topic | Guidance |
Late Submission Policy | No guidance at this time. |
Pre-Award Costs | No guidance at this time. |
No-Cost Extensions | As per current RGPO policy, all grants are eligible to receive an automatically-approved three-month no cost time extension at the conclusion of their project period. |
Carry Forward of an Unobligated Balance | As per current RGPO policy, carryforward of up to 25% of original annual direct cost is allowable without approval. |
Expenditure of Awards Funds for Salaries, Stipends and Other Project Activities |
|
Delays in Research Progress Including Financial and Other Reporting |
|
Travel Costs |
Costs related to the cancellation of events, travel, or other activities necessary and reasonable for the performance of the approved scope of work, or the pausing and restarting of grant funded activities due to the public health emergency, may be charged to the RGPO grant with which those events, travel, or activities were associated. |